Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $73.89 (+269.4%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 43%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/23/2016 JPMorgan Downgrade Neutral
(Overweight)
35.00
(50.00)
21.64 20.00 -7.58% Details
3/21/2016 Barclays Downgrade Equalweight
(Overweight)
34.00
(135.00)
26.98 20.00 -25.87% Details
Like VRX Ratings? Also take a look at AGN, WBA, PRGO, MNK

VRX Ratings News